0001209191-18-019209.txt : 20180313
0001209191-18-019209.hdr.sgml : 20180313
20180313162234
ACCESSION NUMBER: 0001209191-18-019209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180312
FILED AS OF DATE: 20180313
DATE AS OF CHANGE: 20180313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOUGHLIN JAMES J
CENTRAL INDEX KEY: 0001276550
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 18686724
MAIL ADDRESS:
STREET 1: DORSEY & WHITNEY LLP
STREET 2: 250 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10177
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-12
0
0000816284
CELGENE CORP /DE/
CELG
0001276550
LOUGHLIN JAMES J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
1
0
0
0
Common Stock
2018-03-12
4
M
0
9250
27.18
A
33611
D
Common Stock
2018-03-12
4
S
0
9250
92.01
D
24361
D
Common Stock
1800
I
Family Trust
Stock Option (right to buy)
27.18
2018-03-12
4
M
0
9250
D
2018-03-17
Common Stock
9250
0
D
The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $91.46 to $92.47, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The option was fully exercisable.
The option was issued pursuant to the Company's 1995 Non-Employee Directors' Incentive Plan.
/s/ Peter N. Kellogg, Attorney-in-Fact
2018-03-13